Optilink Trademark Details

This mark is dead with a status of Abandoned - After Inter-Partes Decision. The last case file activity for this mark occured 18 years ago on Wednesday, February 22, 2006, according to the United State Patent & Trademark Office
Word Mark Optilink
Status Dead 604 — Abandoned - After Inter-Partes Decision

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 78372836
Status Date Wednesday, February 22, 2006
Filing Date Wednesday, February 22, 2006

Correspondent

NADINE P. FLYNN
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK, NY 10154

Case File Statements

Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 8 — Abandoned
Status Date Wednesday, February 22, 2006
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.